EarningsQ3 2023 Earnings Report

Mirum Pharmaceuticals (MIRM) Q3 2023 Earnings Report

0 Followers

MX:MIRM Q3 2023 EPS Results

Actual EPS-$10.48

Consensus EPS-$11.55

Beat/MissBeat by +$1.07

One Year Ago EPS-$18.76

Actual Revenue$877.72M

Expected Revenue$709.90M

Beat/MissBeat by +$167.82M

YoY Revenue Growth+154.13%

QuarterQ3 2023

Date11/02/2023

TimeAfter Close

Conference CallThursday, November 2, 2023

MX:MIRM Upcoming Earnings

Mirum Pharmaceuticals's next earnings date is estimated for November 17, 2026, based on past reporting schedules.

MX:MIRM Q3 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 17, 2026	2026 (Q3)	-8.99 / -	0.92	―
Aug 05, 2026	2026 (Q2)	-13.66 / -19.49	-2.207	-783.33% (-17.29)
May 06, 2026	2026 (Q1)	-6.71 / -246.99	-5.517	-4376.67% (-241.48)
Feb 25, 2026	2025 (Q4)	1.03 / -1.84	-9.012	79.59% (+7.17)
Nov 04, 2025	2025 (Q3)	-2.57 / 0.92	-5.517	116.67% (+6.44)
Aug 06, 2025	2025 (Q2)	-6.00 / -2.21	-9.563	76.92% (+7.36)
May 07, 2025	2025 (Q1)	-6.07 / -5.52	-9.931	44.44% (+4.41)
Feb 26, 2025	2024 (Q4)	-4.74 / -9.01	-11.586	22.22% (+2.57)
Nov 12, 2024	2024 (Q3)	-8.26 / -5.52	-10.483	47.37% (+4.97)
Aug 07, 2024	2024 (Q2)	-8.68 / -9.56	-35.679	73.20% (+26.12)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed